In collaboration with the University of Massachusetts Medical School (UMMS) and Auburn University (AU), Lysogene is developing IND -
supporting preclinical studies using AAV gene therapy technology to translate the initial proof of concept into a viable drug development program to the benefit of patients in urgent need.
Through the collaboration, Lysogene, UMMS and AU will develop IND -
supporting preclinical studies in GM1 - gangliosidosis using AAV gene therapy technology.
The social venture company within the foundation is moving fast on getting the first steps done; however, it won't have enough money to finish the project, and has conducted fundraising campaigns which have helped to
support the preclinical studies that are paving the way for the first human trial.
Not exact matches
The new data builds off several
preclinical studies supporting the use of ibrutinib with CAR therapy.
Many factors may cause differences between current expectations and actual results including unexpected safety or efficacy data observed during
preclinical or clinical
studies, clinical trial site activation or enrollment rates that are lower than expected, changes in expected or existing competition, changes in the regulatory environment, failure of Syndax's collaborators to
support or advance collaborations or product candidates and unexpected litigation or other disputes.
[21] In the recently presented FLAURA
study, in which osimertinib was used in untreated patients with advanced EGFR - mutant NSCLC, the HR for systemic disease control and CNS control similarly favored osimertinib over erlotinib or gefitinib,
supporting the
preclinical data that showed osimertinib's penetration across the BBB and providing
support for using this agent in first - line management of EGFR - mutant patients with brain metastases.
Together our data
support the notion that targeting DGKζ, a negative regulator of T cell activation, or other regulators of Erk activation, could be useful in the treatment of human malignancy and that additional
preclinical studies of intracellular «brakes» on T cell activation are warranted.
Together with the research and clinical resources of the nation's leading cancer hospital, we have the ability to take a program from a research hypothesis all the way to a clinical candidate
supported by robust
preclinical data, and into early phase clinical
studies in well - defined patient populations.
«The initiation of the NPT088 Phase 1b trial is
supported by a substantial
preclinical development program and the recent successful completion of a Phase 1a
study in healthy volunteers.
These new
preclinical studies provide
support for advancing the Ad26 / MVA prime - boost vaccine candidate into clinical development.
The Clinical Pharmacology Resource
supports investigators in the design, analysis, and interpretation of clinical pharmacology objectives in
preclinical and clinical
studies, including chemoprevention and epidemiological
studies.